Tertinat for atherosclerosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Aug 2024: Trial started, NCT06590012
  2. 19 Sep 2024: Trial registered, NCT06590012

The trials

NCT06590012: SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY

State
Under way
Phase
Phase 2
People
1,228 taking part
Started
29 Aug 2024
Primary completion
15 Jul 2027
Arms
Tertinat
Results
None posted
  1. 29 Aug 2024: Trial started
  2. 19 Sep 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.